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Abstract
Background: Nanoparticles (NPs) can potentially cause adverse effects on organ, tissue, cellular, subcellular and
protein levels due to their unusual physicochemical properties. Advances in nanotechnology have identified
promising candidates for many biological and biomedical applications. Since the properties of NPs differ from that
of their bulk materials, they are being increasingly exploited for medical uses and other industrial applications. The
aim of the present study was to investigate the particle-size effect of gold nanoparticles (GNPs) on the hepatic
tissue in an attempt to cover and understand the toxicity and the potential threat of their therapeutic and
diagnostic use.
Methods: To investigate particle-size effect of GNPs on the hepatic tissue, a total of 70 healthy male Wistar-Kyoto
rats were exposed to GNPs received 50 or 100 ul of GNPs infusion of size (10, 20 and 50 nm for 3 or 7 days).
Results: In comparison with respective control rats, exposure to GNPs doses has produced alterations in the
hepatocytes, portal triads and the sinusoids. The alterations in the hepatocytes were mainly summarized as
hydropic degeneration, cloudy swelling, fatty degeneration, portal and lobular infiltrate by chronic inflammatory
cells and congestive dilated central veins.
Conclusions: The induced histological alterations might be an indication of injured hepatocytes due to GNPs
toxicity that became unable to deal with the accumulated residues resulting from metabolic and structural
disturbances caused by these NPs. These alterations were size-dependent with smaller ones induced the most
effects and related with time exposure of GNPs. The appearance of hepatocytes cytoplasmic degeneration and
nuclear destruction may suggest that GNPs interact with proteins and enzymes of the hepatic tissue interfering
with the antioxidant defense mechanism and leading to reactive oxygen species (ROS) generation which in turn
may induce stress in the hepatocytes to undergo atrophy and necrosis. More histomorphologcal, histochemical
and ultrastrucural investigations are needed in relation of the application of GNPs with their potential threat as a
therapeutic and diagnostic tool.
Keywords: gold nanoparticles, size, hepatic tissue, histology, hydropic degeneration, nanotoxicity, rats
Introduction
In vivo studies in rats exposed to aerosols of GNPs
revealed that the NPs were rapidly taken into the system
with the highest accumulation in the lungs, aorta, eso-
phagus and olfactory bulb [1]. Moreover, particles of
nano-dimension are believed to be more biologically
reactive than their bulk counter parts due to their small
size and larger surface area to volume ratio [1,2].
Gold in its bulk form has long been considered an
inert, noble metal with some therapeutic and even med-
icinal value hence GNPs are thought also to be relatively
non-cytotoxic [3]. Yet there are differing reports of the
extent of the toxic nature of these particles owing to the
different modifications of the GNPs, surface functional
attachments and shape and diameter size of the nano-
spheres [4,5]. Moreover, the metallic nature of the metal
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encourages the production of reactive oxygen species
(ROS) leading to oxidative stress [6,7].
Although some scientists consider NPs as nontoxic,
other studies reporting the toxic effects induced by NPs
[8-10]. Although some NPs may appear to be nontoxic,
other cellular mechanisms such as cell signaling and
other normal cellular functions may be disrupted and
are currently undergoing further investigation [11,12].
The toxicity of NPs is being addressed by a number of
standardized approaches with in vitro, in vivo as well as
detailed genomic or biodistribution studies [12].
It has been shown that NPs may produce in vitro toxi-
city in some cell-based assays, but not in others. This
m a yb ear e s u l to fi n t e r f e r e n c ew i t ht h ec h e m i c a l
probes, differences in the innate response of particular
cell types, or other factors [13]. In addition, GNPs are
used as carriers for the delivery of drugs and genes [14].
The histological and the histochemical characteriza-
tion in the hepatic tissues due to GNPs have not yet
been identified and documented. In the present study,
an attempt has been made to characterize the possible
histological alterations in the hepatic tissues following
intraperitoneal administration of GNPs and, if so,
whether are related to the size of these NPs and the
time of exposure.
The present study was carried out to investigate the
particle-size effect of GNPs on the hepatic tissue in an
attempt to cover and understand the toxicity and poten-
tial threat of their therapeutic and diagnostic use in rela-
tion with the time of exposure.
Materials and methods
A total of 70 healthy male Wistar-Kyoto rats obtained
from the Laboratory Animal Center (College of Phar-
macy, King Saud University, Saudi Arabia). The rats
nearly of the same age (12 weeks old) and weighing
220-240 gm of King Saud University colony were used.
Animals were randomly divided into groups, 12 GNPs-
treated rats groups and one control group (NG).
The 10, 20 and 50 nm GNPs were administered intra-
peritonealy in rats for periods of 3 or 7 days as shown
in Table 1.
The rats were maintained on standard laboratory
rodent diet pellets and were housed in humidity and
temperature-controlled ventilated cages on a 12 h day/
Table 1 The intraperitoneal administration of 10, 20 and 50 nm GNPs in rats for periods of 3 or 7 days
Groups Infusion dose, size and exposure duration of GNPs
Control received no gold nanoparticles (GNPs; n = 10)
G1A received infusion of 50 μl GNPs of size 10 nm for 3 days (n = 5)
G1B received infusion of 50 μl GNPs of size 10 nm for 7 days (n = 5)
G2A received infusion of 50 μl GNPs of size 20 nm for 3 days (n = 5)
G2B received infusion of 50 μl GNPs of size 20 nm for 7 days (n = 5)
G3A received infusion of 50 μl GNPs of size 50 nm for 3 days (n = 5)
G3B received infusion of 50 μl GNPs of size 50 nm for 7 days (n = 5)
G4A received infusion of 100 μl GNPs of size 10 nm for 3 days (n = 5)
G4B received infusion of 100 μl GNPs of size 10 nm for 7 days (n = 5)
G5A received infusion of 100 μl GNPs of size 20 nm for 3 days (n = 5)
G5B received infusion of 100 μl GNPs of size 20 nm for 7 days (n = 5)
G6A received infusion of 100 μl GNPs of size 50 nm for 3 days (n = 5)
G6B received infusion of 100 μl GNPs of size 50 nm for 7 days (n = 5)
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Page 3 of 9night cycle. Two animals from each group were killed
by dislocation of the neck at intervals of 3 and 7 days of
treatment with GNPs. All experiments were conducted
in accordance with the guidelines approved by King
Saud University Local Animal Care and Use Committee.
Fresh portions of the lateral lobes of the liver from
each rat were cut rapidly, fixed in neutral buffered for-
malin (10%), then dehydrated, with grades of ethanol
(70, 80, 90, 95 and 100%). Dehydration was then fol-
lowed by clearing the samples in 2 changes of xylene.
Samples were then impregnated with 2 changes of mol-
ten paraffin wax, then embedded and blocked out. Par-
affin sections (4-5 um) were stained with hematoxylin
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Figure 5
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Page 4 of 9and eosin the conventional histological and stain
according to Pearse [15]. Stained sections of control and
treated rats were examined for alterations in the archi-
tecture, portal triads, hepatocytes, sinusoids and for the
presence of degeneration, necrosis, fatty change and
portal fibrosis.
Results and discussions
Size and morphology of different gold nanoparticles
The 10 and 20 nm GNPs show spherical shape while
the 50 nm GNPs show hexagonal shape. The mean size
for GNPs was calculated from the images taken by the
transmission electron microscope (TEM). The 10 nm
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was of mean size of 20.18 ± 1.80 and the 50 nm GNPs
was of mean size of 50.73 ± 3.58. The high electron
densities of GNPs as well as the homogeneity of the par-
ticles shape and size make them highly conspicuous
under the TEM. In addition, relatively simple methods
can be applied to obtain the populations of GNPs of dif-
ferent average sizes which allow simultaneous detection
of several targets.
Histological Alterations
In comparison with the control group, the following his-
tological alterations were detected in the liver tissue of
GNPs-treated rats. These histological alterations were
observed in Figures 1,2,3,4,5,6,7,8,9,10,11 and 12 and
can be summarized as shown in Table 2.
The cloudy swelling might be exhibited as a result of
disturbances of membranes function that lead to mas-
sive influx of water and Na
+ due to GNPS effects. Cellu-
lar swelling might be accompanied by leakage of
lysosomal hydrolytic enzymes that lead to cytoplasmic
degeneration and macromolecular crowding [16].
Hydropic degeneration is a result of ion and fluid
homestasis that lead to an increase of intracellular water
[17]. The vacuolated swelling of the cytoplasm of the
hepatocytes of the GNPs treated rats might indicate
acute and subacute liver injury induced by these NPs.
Some studies indicate that nuclear polymorphism is
seen in hepatic dysplasia and carcinomatous lesion [18].
Binucleation represents a consequence of cell injury and
is a sort of chromosomes hyperplasia which is usually
seen in regenerating cells [19].
Occasional inflammatory cells infiltration was seen in
the portal triads and the perioral zones of GNPs treated
rats. The infiltrate cells we r em a i n l yl y m p h o c y t e sa n d
plasma cells. This infiltration was more prominent after
7 days of administration and in rats received 100 μl
than those received 50 μl. The appearance of inflamma-
tory cells in the hepatic tissue may suggest that GNPs
could interact with proteins and enzymes of the hepatic
interstitial tissue interfering with the antioxidant defense
mechanism and leading to reactive oxygen species
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matory response [20].
The sinusoidal Kupffer cells became prominent and
increased in number due to GNPs exposure. This
change was more prominent at 10 nm GNPs with dose
of 100 μl than 20 nm and 50 nm GNPS and more after
7 days of administration than rats exposed to GNPs for
3 days. Kupffer cells activation might indicate that
GNPs activate the phagocytic activity of the sinusoidal
cells by increasing the number of Kupffte cells to help
in removing the accumulated GNPs where lysosomes
are involved in the intracellular breakdown into small
metabolic products. The produced Kupffer cells hyper-
plasia might be correlated with the amount of injurious
to the hepatic tissue induced by GNPs intoxication and
represents a defense mechanism of detoxification. Kupf-
fer cell hyperplasia is contributed to hepatic oxidative
stress [21].
Fatty change was observed in some swelling hepato-
cytes of rats exposed to 100 μl of 10 nm GNPs and to les-
ser extent in the ones exposed to larger particles. This
hepatic liposis was more frequent in rat exposed to the
GNPs for 7 days than those received the treatment for 3
days. Hepatocytes fatty change might be due to lipid per-
oxidation that leads to rough endoplasmic damage and
detachment of the cytoplasmic lipoprotein and indicate
abnormal fat metabolism [22]. The seen hepatocytes
abnormal retention of lipids in the present investigation
induced by GNPs might indicate toxic injury to liver in
the form of hepatocytes liposis by these particles.
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some hepatocytes of GNPs treated rats. This alteration was
detected in the liver of rats exposed to 10 nm size particles
and to lesser extent with 20 nm particles but was not seen
with those exposed to 50 nm size particles. Apoptic altera-
tion might be followed organelles swelling specially mito-
chondria, endoplasmic reticulum and rupture of lysosomes
which might lead to amorphous eosinophilic cytoplasm as
an initial sign in the sequence of hepatocytes necrosis
before shrinking and dissolution of nulei [23]. The seen
hepatocytes necrosis due to GNPs exposure might indicate
oxidative stress on these cells by glutathione depletion.
Conclusions
H i s t o l o g i c a la l t e r a t i o n sb yG N P se x p o s u r ea ss h o w ni n
the results of the present work could be an indication of
injured hepatocytes due to GNPs toxicity that become
unable to deal with the accumulated residues resulting
from metabolic and structural disturbances caused by
these particles. One might conclude that these alterations
are size-dependent with smaller ones induced more
damage with relation with the time exposure of GNPs.
The appearance of hepatocytes cytoplasmic degenera-
tion and nuclear destruction may suggest that GNPs
interact with proteins and enzymes of the hepatic tissue
interfering with the antioxidant defense mechanism and
leading to reactive oxygen species (ROS) generation
which in turn may induce stress in the hepatocytes to
undergo atrophy and necrosis.
More histomorphologcal, histochemical and ultrastru-
cural investigations are needed to correlate the biomedi-
cal application of GNPs with the potential threat of
their therapeutic and diagnostic use.
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Table 2 Histological alterations induced in GNPs-treated rats
Figure 1 GNPs-normal rat demonstrating benign looking hepatic lobule and hepatocytes surrounding a central vein
Figure 2 GNPs-treated rat received 50 μl of 10 nm particles for 3 days demonstrating: Congested central vein with portal infiltrated by
chronic inflammatory cells (40 × 3); Liver section showed widely dilated congested central vein (40 × 7); necrotic hepatocytes (100 × 3)
Figure 3 GNPs-treated rat received 100 μl of 10 nm particles for 7 days demonstrating: Liver section widely dilated congested central
vein (40 × 3) with hepatocytes disarray and cloudy swelling of liver hepatocytes (40 × 5)
Figure 4 GNPs-treated rat received 50 μl of 20 nm particles for 3 days demonstrating: lobular infiltrate by chronic inflammatory cells (40
× 3) congested hepatic sinusoids containing red blood cells (40 x4)
Figure 5 GNPs-treated rat received 50 μl of 10 nm particles for 7 days demonstrating dilated congested blood sinusoids (40 × 2)
Figure 6 GNPs-treated rat received 50 μl of 50 nm particles for 3 days demonstrating: Widely dilated congested central vein with dilated
congested liver sinusoids with hepatocytes cloudy swelling (40 × 1); Fatty degeneration focally affecting the liver lobules (40 × 10) and
(40 × 8); Fatty degeneration focally affecting the liver lobules (100 × 2)
Figure 7 GNPs-treated rat received 100 μl of 10 nm particles for 3 days demonstrating: Liver hepatocytes with lobular lymphocytic
infiltrate (40 × 1); prominent diffuse fatty degeneration (40 × 3) & (100 × 3); prominent diffuse fatty degeneration (40 × 3) & (100 × 3);
congested dilated blood sinusoids (40 × 9); scattered fatty degeneration of liver hepatocytes with focus of inflammatory cells infiltrate of
liver lobules; diffuse fatty degeneration
Figure 8 GNPs-treated rat received 100 μl of 10 nm particles for 7 days demonstrating: Dilated congested blood vessels (100 × 1);
congested blood sinusoids (40 × 4); fatty degeneration of liver hepatocytes (100 × 2); increased sinusoidal Kupffer cells (100 × 4)
Figure 9 GNPs-treated rat received 100 μl of 20 nm particles for 3 days demonstrating: Inflammatory cells infiltrate of liver lobules and
dilated congested central vein (40 × 4)
Figure 10 GNPs-treated rat received 100 μl of 20 nm particles for 7 days demonstrating: Liver hepatocytes with binucleated cells (100 ×
1); dilated congested central vein (40 × 2)
Figure 11 GNPs-treated rat received 100 μl of 50 nm particles for 3 days demonstrating: Scattered lobular inflammatory cells infiltrate (40
× 7) and (100 × 8); scattered few cloudy swellings on (40 × 8)
Figure 12 GNPs-treated rat received 100 μl of 50 nm particles for 7 days demonstrating: No major pathological effect seen. Just few liver
hepatocytes with binucleation or even trinuclei noticed; no other effects (100 × 2)
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